Trimetrexate
N/A
Report date: 2026/03/30 17:02:26
Base Information
Drug NameTrimetrexate
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAuspexPfizer IncMedimmune Llc
Active IndicationsN/A
Inactive Indications